Subscribe to Newsletter

Biochemistry and molecular biology

Inside the Lab Microbiology and immunology

Navigating 21st Century Virology

| Malur Sudhanva

Virology remains a rapidly changing field and the diagnostic clinical laboratory must keep abreast of newer viruses, targets and technologies

Diagnostics Genetics and epigenetics

Unlocking the Value of RNA

| Xiao-Jun M

RNA biomarkers lag behind DNA and proteins in clinical use because of the limitations of lab technology – but new analytical tools could now make RNA a useful tool in the pathologist’s kit

Diagnostics Oncology

High Hopes for Pancreatic Cancer Urine Test

| Michael Schubert

A new three-biomarker panel may allow early detection of the disease at a stage when curative surgical treatment may still be possible

Diagnostics Digital and computational pathology

The Changing Face of Pathology

| Han van Krieken

Han van Krieken discusses the ways in which laboratory medicine is evolving, the difference between old and young pathologists, and the obstacles facing both of them today

Outside the Lab Hematology

From Kitchen to Clinic

| Michael Schubert

A new blood test based on food science principles may hold the key to predicting breast cancer earlier than ever

Diagnostics Oncology

Molecular Clues to Skin Cancer

| Roisin McGuigan

A better understanding of melanoma could lead to new strategies for tackling therapy resistance

Diagnostics Genetics and epigenetics

A Personalized Reality

| Matthew Smith , George Burghel

Next generation sequencing holds much promise for personalized cancer diagnosis, treatment and management, but how is this being realized and what does the future hold?

Outside the Lab Point of care testing

Nanoparticle Nephrology

| Michael Schubert

A new device combining nanoparticles with pregnancy testing technology may provide rapid, inexpensive kidney disease diagnosis and monitoring

Diagnostics Regulation and standards

Hitting the Mark

| Roisin McGuigan

New US guidelines for colorectal cancer testing highlight the importance of molecular markers

Diagnostics Biochemistry and molecular biology

Benchmarking Biomarkers of Myocardial Infarction

| Roisin McGuigan

What does analysis of the last five years of literature on myocardial infarction biomarkers tell us about the priorities of this field of research and the major contributors to it?

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register